$1.31
-0.05 (-3.69%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+359.8% upside
Low Target
$4.29
Average Target
$6.00
High Target
$7.91
Current Price
$1.31
Current
$1.31
$1.31
Target
$6.00
$6.00
$4.29
$6.00 avg
$7.91
Scenario Analysis
Bear Case
$4.29
228.7%
Low target
Base Case
$6.00
+359.8%
Avg target
Bull Case
$7.91
+506.1%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$2.95
-55.7% from high
52-Week Low
$0.80
+63.5% from low
Target vs 52W High
$6.00
+103.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |